CNNA (Cann American) Research & Development: $0.00 Mil (TTM As of Aug. 2012)


What is Cann American Research & Development?

Cann American CNNA -7.41% Research & Development is $0.00 Mil as of Aug. 2012.

Research & Development is the aggregate amount of research and development expenses during the year. Cann American's Research & Development for the three months ended in Aug. 2012 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2012 was $0.00 Mil.

Cann American  (OTCPK:CNNA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cann American Research & Development Related Terms

Cann American Research & Development Historical Data

* Premium members only.

The historical data trend for Cann American's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cann American Research & Development Chart

Cann American Annual Data
Trend Feb08 Feb09 Feb10 Feb11 Feb12
Research & Development
0.00 0.01 0.00 0.00 0.00

Cann American Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cann American Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Cann American (CNNA) has a Research & Development of $0.00 Mil as of Aug. 2012. Research and development expense is the total cost for research and development activities. View historical data on Cann American and its competitors.
Is Cann American's Research & Development too high?
Cann American's current Research & Development is $0.00 Mil.
How does Cann American's Research & Development compare to GLUC and HISP?
Cann American's Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cann American and its competitors. Cann American's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann American stock overvalued right now?
Cann American (CNNA) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cann American (CNNA), the current Research & Development is $0.00 Mil as of Aug. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cann American Business Description

Address 320 Santana Drive, Suite C, Cloverdale, CA, USA, 95425
Cann American Corp is engaged in developing assets in legal cannabis and hemp industries. It is focused on consulting, infrastructure developming assets, product marketing and strategic acquisitions within the legal cannabis and hemp industries.